NCT07334301
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07334301
Title A Multi-Arm, Platform Trial For Relapsed Neuroblastoma (BEACON2)
Acronym BEACON2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Birmingham
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries NZL | GBR | BEL | AUT | AUS


No variant requirements are available.